$14.71
-0.13[-0.88%]
At close: Apr 26
$14.71
0[0.00%]
After Hours: 4:43PM EDT
Y-mAbs Therapeutics
(NASDAQ:YMAB)Y-mAbs Therapeutics Stock (NASDAQ:YMAB), Guidance and Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Date Announced | ticker | Company Name | Period | Period Year | Min EPS | Max EPS | Estimate | Min Rev | Max Rev | Revenue Estimate | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/29/2024 | YMAB | Y-mAbs Therapeutics | FY | 2024 | — | — | — | $95.00M | $100.00M | $96.27M | Get Alert |
| 01/09/2024 | YMAB | Y-mAbs Therapeutics | FY | 2023 | — | — | — | $80.00M | $85.00M | $82.39M | Get Alert |
| 11/13/2023 | YMAB | Y-mAbs Therapeutics | FY | 2023 | — | — | — | $80.00M | $85.00M | $83.76M | Get Alert |
| 08/10/2023 | YMAB | Y-mAbs Therapeutics | FY | 2023 | — | — | — | $80.00M | $85.00M | $82.79M | Get Alert |
| 11/07/2022 | YMAB | Y-mAbs Therapeutics | FY | 2022 | — | — | — | $45.00M | $50.00M | $51.75M | Get Alert |
| 08/08/2022 | YMAB | Y-mAbs Therapeutics | FY | 2022 | — | — | — | $45.00M | $50.00M | $60.18M | Get Alert |
| 04/27/2022 | YMAB | Y-mAbs Therapeutics | Q1 | 2022 | — | — | — | $10.50M | $10.50M | $10.99M | Get Alert |
| 04/27/2022 | YMAB | Y-mAbs Therapeutics | FY | 2022 | — | — | — | $45.00M | $50.00M | $67.81M | Get Alert |
FAQ
What is the most recent guidance for Y-mAbs Therapeutics (YMAB)?
There have been no specific sales or earnings guidance reported for Y-mAbs Therapeutics in recent months.
Browse guidance and forecast on all stocks.